Furthermore, we have shown recently that targeting the lactate/pyruvate metabolism in cancer cells by a pharmacological or genetic inhibition of LDHA/B results in decreased cytosolic Hsp90, Hsp70 and Hsp27 levels and a reduced membrane Hsp70 expression (6). Here, LDHA is linked to cancer.